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Opposing roles for DNA replication
initiator proteins ORC1 and CDC6 in
control of Cyclin E gene transcription
Manzar Hossain, Bruce Stillman*
Cold Spring Harbor Laboratory, Cold Spring Harbor, United States
Abstract Newly born cells either continue to proliferate or exit the cell division cycle. This
decision involves delaying expression of Cyclin E that promotes DNA replication. ORC1, the Origin
Recognition Complex (ORC) large subunit, is inherited into newly born cells after it binds to
condensing chromosomes during the preceding mitosis. We demonstrate that ORC1 represses
Cyclin E gene (CCNE1) transcription, an E2F1 activated gene that is also repressed by the
Retinoblastoma (RB) protein. ORC1 binds to RB, the histone methyltransferase SUV39H1 and to its
repressive histone H3K9me3 mark. ORC1 cooperates with SUV39H1 and RB protein to repress
E2F1-dependent CCNE1 transcription. In contrast, the ORC1-related replication protein CDC6
binds Cyclin E-CDK2 kinase and in a feedback loop removes RB from ORC1, thereby hyper-
activating CCNE1 transcription. The opposing effects of ORC1 and CDC6 in controlling the level of
Cyclin E ensures genome stability and a mechanism for linking directly DNA replication and cell
division commitment.
DOI: 10.7554/eLife.12785.001
Introduction
In addition to its role in the initiation of DNA replication, ORC1, the largest subunit of the Origin
Recognition Complex (ORC) controls Cyclin E-dependent duplication of centrosomes and centrioles
in cells by acting as an inhibitor of Cyclin E-CDK2 activity (Hemerly et al., 2009; Hossain and Still-
man, 2012). The Cyclin E-CDK2 kinase inhibitory activity is compromised by ORC1 Meier-Gorlin syn-
drome mutations that also alter the interaction between ORC1 and histone H4K20me2 (Hossain and
Stillman, 2012; Kuo et al., 2012; Zhang et al., 2015; Bicknell et al., 2011b; Bicknell et al., 2011a;
de Munnik et al., 2012). Unlike the well-characterized yeast complex that is a stable, six subunit
complex throughout the cell division cycle, ORC in human cells is a very dynamic complex
(Sasaki and Gilbert, 2007; DePamphilis, 2005). ORC1 binds to mitotic chromosomes as cells enter
into mitosis (Kara et al., 2015; Okuno et al., 2001), and in human cells, it is modified by ubiquitin
and then degraded during the G1 to S phase transition (Abdurashidova et al., 2003; Kara et al.,
2015; Kreitz et al., 2001; Mendez et al., 2002; Ohta et al., 2003; Siddiqui and Stillman, 2007;
Tatsumi et al., 2000). The assembly of the full ORC occurs in mid G1 phase of the cell division cycle
in preparation for its role in assembly of the pre-replicative complex (pre-RC) at sites across chromo-
somes (Kara et al., 2015; Siddiqui and Stillman, 2007).
The ORC1-related protein CDC6 is also required for pre-RC assembly, but it is targeted for pro-
teasome degradation by the SCFCyclin F ubiquitin ligase complex late in the cell cycle and the ana-
phase-promoting complex/cyclosome (APC/C) in early G1 phase and then stabilized in mid G1
phase by Cyclin E-CDK2-mediated phosphorylation (Mailand and Diffley, 2005; Petersen et al.,
2000; Walter et al., 2016). This phosphorylation is mediated by the direct interaction between
Cyclin E and CDC6 and CDC6 and Cyclin E-CDK2 cooperate to promote the initiation of DNA repli-
cation (Coverley et al., 2002; Furstenthal et al., 2001; Cook et al., 2002).
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As proliferating cells divide, they must make a decision whether to continue to proliferate or
enter into proliferative quiescence. This decision is made by a complex regulatory process known as
START in yeast and the restriction point in mammalian cells (Johnson and Skotheim, 2013). Key
among these regulators are the Cyclin D-CDK4/6 kinases that mono-phosphorylate the retinoblas-
toma (RB) protein and contributes to the release of repression of E2F-transcription factors
(Narasimha et al., 2014; Ewen et al., 1993; Hinds et al., 1992; Lundberg and Weinberg, 1998;
Resnitzky et al., 1994). E2F1-regulated genes include genes encoding Cyclin E (CCNE1) and CDC6
(Hateboer et al., 1998; Ohtani et al., 1998; Yan et al., 1998; DeGregori et al., 1995). Cyclin
E-CDK2 amplifies the phosphorylation of RB, but how this is achieved is not known
(Narasimha et al., 2014). Here, we demonstrate that ORC1 is required for repression of the gene
encoding Cyclin E and that CDC6 is involved in relieving the repression in cooperation with Cyclin
E-CDK2. We suggest that ORC1 establishes a period in the newly born cells during which Cyclin E is
not expressed, allowing time for the cells to decide whether to proliferate again or enter into repli-
cative quiescence.
Results
ORC1 binds to RB and SUV39H1 and represses CCNE1 gene
transcription
Apart from its role in DNA replication, human ORC1 controls centriole and centrosome copy num-
ber by binding and inhibiting the kinase activity of Cyclin E-CDK2 (Hemerly et al., 2009). That
work suggested that ORC1 might also control Cyclin E by regulating its protein level during the G1
phase of the cell division cycle. To determine if this was the case, ORC1 was depleted using siRNA
in U2OS cells that had been synchronized in mitosis by nocodazole treatment and released into the
next cell cycle. As early as 9 hr post release, Cyclin E protein level was elevated in ORC1-depleted
U2OS cells, compared to control siRNA treated cells (Figure 1A). The expression of CCNE1 mRNA
eLife digest Living cells must replicate their DNA before they divide so that the newly formed
cells can each receive an identical copy of the genetic material. Before DNA replication can begin, a
number of proteins must come together to form so-called pre-replicative complexes at many
locations along the DNA molecules. These protein complexes then serve as landing pads for many
other DNA replication proteins.
One component of the pre-replicative complex, a protein called ORC1, helps to recruit another
protein called CDC6 that in turn acts with Cyclin E to promote the replication of the DNA. Cyclin E
is a protein that is only expressed when cells commit to divide. Previous research has shown that a
lack of ORC1 causes the levels of Cyclin E to rise in human cells, but it was not understood how cells
regulate the levels of Cyclin E.
Now, Hossain and Stillman show that the ORC1 protein switches off the gene that encodes Cyclin
E early on in newly born cells, and therefore prevents the Cyclin E protein from being produced. The
experiments show that ORC1 does this by binding near one end of the gene for Cyclin E and
interacting with two other proteins to inactivate the gene. Thus, ORC1 establishes a period when
Cyclin E is absent from a newly formed cell. This essentially gives the cell time to ‘decide’ (based on
external cues and its own signaling) whether it will divide again or enter into a non-dividing state.
When a cell does decide to divide, the levels of CDC6 rise. CDC6 is another component of the
pre-replicative complex and Hossain and Stillman find that CDC6 works to counteract the effects of
ORC1 and reactivate the gene for Cyclin E. This activity leads to a dramatic increase in the
production of Cyclin E, which in turn allows the cells to commit to another round of DNA replication
and division.
The opposing effects of ORC1 and CDC6 control the levels of Cyclin E and provide a link
between DNA replication and a cell’s decision to divide. Further work is now needed to see whether
ORC1 inactivates other genes in addition to the one that encodes Cyclin E.
DOI: 10.7554/eLife.12785.002
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Figure 1. ORC1 represses Cyclin E gene expression and interacts with RB. (A–B) Nocodazole arrested U2OS cells were transfected with control or
ORC1 siRNA then released into the next cycle. (A) protein levels were estimated by immunoblotting with antibodies against ORC1, Cyclin E, Cyclin A
and a-Tubulin. Low and high indicates different exposures. (B) mRNA levels of ORC1, Cyclin E (CCNE1), Cyclin A (CCNA2) and GAPDH. Quantitation of
mRNA levels from multiple experiments is shown in Figure 1—figure supplement 1. (C–E) Interaction between ORC1 and RB or its pocket mutants.
GFP, GFP-tagged wild-type or mutant RB were co-transfected in HEK293 cells with either ORC1-Flag or empty vector. Immunoprecipitation with anti-
Figure 1 continued on next page
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increased at all times following ORC1 depletion in synchronized U2OS cells (Figure 1B) and quanti-
tation of multiple experiments showed significant increases from 6–24 hr post release (Figure 1—
figure supplement 1A–D). This data suggests that ORC1 inhibits CCNE1 gene expression.
Transcription of the gene encoding Cyclin E (CCNE1) is known to be regulated by the E2F1 tran-
scription factor and to be repressed by RB protein (Nielsen et al., 2001; Geng et al., 1996;
DeGregori et al., 1995), a member of the so-called ’pocket protein’ family (Dick and Rubin, 2013;
Dyson, 1998; Giacinti and Giordano, 2006). Since ORC1 binds RB (Mendoza-Maldonado et al.,
2010), we explored a role for ORC1 in transcriptional repression of the CCNE1 gene.
RB was expressed as a fusion to the maltose binding protein (MBP) and it bound to S35-labelled
ORC1 protein (Figure 1—figure supplement 2A). RB binds other binding partners dependent on a
canonical LxCxE motif and although ORC1 has a conserved LPCRD/E sequence, it was not required
for the interaction between ORC1 and RB (Figure 1—figure supplement 2A and B). Consistent with
this finding, two pocket mutants within RB (R661W and N757F) that are defective in binding to
LxCxE containing proteins (Chen and Wang, 2000) showed no defect in binding to ORC1 in vitro
(Figure 1—figure supplement 2C) or in vivo (Figure 1C). In fact, the mutant RB proteins bound
ORC1 better than the wild type, perhaps due to loss of competition between ORC1 and other RB
binding proteins or due to conformational changes in RB. When Green Fluorescent Protein (GFP)-RB
fusion protein was expressed in cells with ORC1-Flag-tagged protein, the ORC1-Flag protein bound
WT and pocket mutant RB, but other ORC subunits did not bind to RB (Figure 1D). We confirmed
this observation by showing that immunoprecipitation with anti-ORC2 or anti-ORC3 antibodies failed
to precipitate GFP-RB or its mutants, but did bind ORC1-Flag (Figure 1E). Given that the ORC1-RB
interaction is independent of other ORC subunits, it suggests that ORC1 has additional functions
that are separate from its role in DNA replication.
The phosphorylation of RB is an important step that relieves repression of E2F target genes
(Rubin, 2013). In the presence of purified Cyclin E-CDK2 kinase plus ATP RB no longer bound to
ORC1 (Figure 1—figure supplement 2A and C), suggesting that Cyclin E might feedback and
relieve repression of the CCNE1 gene by disrupting the RB-ORC1 interaction.
RB interacts with chromatin and histone-modifying enzymes to repress E2F1 transcription activity
(Dick and Rubin, 2013). Specifically, it has been suggested that RB binds to the SUV39H1 histone
methyltransferase that tri-methylates histone H3K9 and then HP1a binds to histone H3K9me3 and
that these direct interactions contribute to repression of CCNE1 transcription (Nielsen et al., 2001).
It is important to note, however, that others suggested that another protein mediates the RB-
SUV39H1 interaction (Vandel et al., 2001). Since ORC1 interacts with both RB and HP1a
(Prasanth et al., 2010), we tested whether ORC1 also interacts with SUV39H1. Using purified pro-
teins we found that both RB and ORC1 directly bound to SUV39H1, and ORC1 directly bound to
CDC6 (Saha et al., 1998) (Figure 2A and Figure 2—figure supplement 1). Under these conditions,
ORC1 bound to HP1a weakly, but the binding increased when higher levels of GST-HP1a were
added, consistent with published data (Prasanth et al., 2010). Although both RB and ORC1 directly
interacted with SUV39H1, ORC1 bound SUV39H1 much better than RB (Figure 2—figure supple-
ment 2A–D). Consistent with the in vitro data, we observed that anti-SUV39H1 antibodies precipi-
tated ORC1 and RB in the RB-positive cells (U2OS and MCF7), with ORC1 being the predominant
interacting protein in MCF7 cells (Figure 2B). Furthermore, the interaction between SUV39H1 with
ORC1 protein did not require RB because anti-ORC1 antibodies co-precipitated SUV39H1 from RB-
Figure 1 continued
Flag antibody (C) or GFP antibody (D) from cell lysates followed by immunoblotting with the indicated antibodies. (E) Cell lysate from HEK293 cells
overexpressing GFP-tagged wild type or mutant RB and ORC1-Flag were immunoprecipitated with normal rabbit serum (NRS) or ORC2 or ORC3
antibodies, immunoblotted with the indicated antibodies. Binding of ORC1 to wild-type and RB mutants and the effect of Cyclin E-CDK2 is shown in
Figure 1—figure supplement 2. GFP, Green fluorescent protein; ORC, Origin Recognition Complex; RB, Retinoblastoma.
DOI: 10.7554/eLife.12785.003
The following figure supplements are available for figure 1:
Figure supplement 1. ORC1 represses Cyclin E gene expression and interacts with RB.
DOI: 10.7554/eLife.12785.004
Figure supplement 2. ORC1 represses Cyclin E gene expression and interacts with RB.
DOI: 10.7554/eLife.12785.005
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Figure 2. ORC1 binds SUV39H1 to control Cyclin E gene transcription. (A) Purified MBP-ORC1 and various GST-fused proteins were mixed and
proteins bound in a GST-pull down were detected by immunoblotting with anti-MBP antibodies. The purified proteins are shown in Figure 2—figure
supplement 1. (B) U2OS and MCF7 cell lysates were immunoprecipitated with SUV39H1 antibody and immunoblotted with the indicated antibodies.
Rabbit IgG served as control antibody. Asterisk indicates the cross-reacting antibody band; arrow indicates the SUV39H1 protein. (C)
Immunoprecipitation from RB-negative SaOS-2 cell lysates with ORC1 antibody or IgG and immunoblotted with antibodies against ORC1, SUV39H1 or
Figure 2 continued on next page
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negative SaOS-2 cells (Figure 2C). This observation was confirmed when GFP-RB or GFP-ORC1
were transiently expressed with T7-SUV39H1 in 293 cells; ORC1 more readily bound to SUV39H1
(Figure 2D), whereas higher levels of GFP-RB were required to observe an interaction with SUV39H1
(Figure 2—figure supplement 3A). Domain mapping demonstrated that SUV39H1 interacted with
ORC1 through its SET domain containing C-terminus, which is required for its histone methyltrans-
ferase (HMT) activity. Moreover, SUV39H1 interacted with ORC1 and ORC1 mutants that could not
be phosphorylated by Cyclin-CDK and did not interact in a complex with other ORC subunits, similar
to the ORC1-RB interaction (Figure 2—figure supplement 3B–C). These data suggest that the
ORC1-SUV39H1 interaction does not require other ORC subunits or CDK phosphorylation of ORC1,
and therefore ORC1 plays a role independent of its role in DNA replication.
Since SUV39H1 tri-methylates histone H3K9 after its de-acetylation by HDAC1, a prerequisite
step for establishing CCNE1 gene repression, we explored the ORC1 protein interactions with dif-
ferent histone H3 modifications (Nicolas et al., 2003; Stewart et al., 2005; Vaute et al., 2002).
Purified ORC1 bound to unmodified or mono-, di- or tri-methylated H3K9 or H3K14-tri-methyl modi-
fications, while the interaction was abolished when histone H3 was acetylated at the same positions
or when H3 serine-10 was phosphorylated, which normally occurs during mitosis (Figure 2E). Thus,
ORC1 can bind to RB, SUV39H1 and to the repressive H3K9-me3 modification on histone H3, sug-
gesting that it might mediate repression of E2F1-dependent CCNE1 transcription.
To test if ORC1 has a role in repression of the E2F1-regulated CCNE1 gene, the CCNE1 pro-
moter was linked to the luciferase-coding region to create a reporter for CCNE1 gene transcription
(Geng et al., 1996). Transfection of plasmids expressing E2F1 and its binding partner DP1 activated
gene expression, whereas expression of ORC1 or SUV39H1 protein repressed CCNE1 expression in
a dose-dependent manner (Figure 2F). In a GAL4-based reporter gene assay, expression of either
GAL4-ORC1 or GAL4-SUV39H1 also repressed transcription of the reporter gene in a dose-depen-
dent manner (Figure 2—figure supplement 4A). In contrast, neither expression of ORC3 nor ORC4
altered E2F1-driven CCNE1 transcription (Figure 2—figure supplement 4B). Moreover, SUV39H1
co-operated with ORC1 to further repress the CCNE1 promoter, but a mutant of SUV39H1 (H324K)
(Li et al., 2002; Rea et al., 2000; Stewart et al., 2005) that has lost its catalytic activity was unable
to do so (Figure 2G). We therefore conclude that ORC1-SUV39H1 co-operation for transcriptional
repression of the CCNE1 gene is mediated through the HMT activity of SUV39H1.
Figure 2 continued
ORC3. (D) HEK293 cells were transiently co-transfected with GFP, GFP-ORC1 or GFP-RB plus T7-SUV39H1 plasmids (2.5 mg each). GFP antibody
immunoprecipitates were immunoblotted with the indicated antibodies. The interaction between ORC1 and SUV39H1 and between RB and SUV39H1 is
shown with purified proteins and quantitated in Figure 2—figure supplement 2. Higher levels of RB are required to demonstrate an interaction with
SUV39H1 in vivo and ORC1 interacts with the SET domain of SUV39H1, Figure 2—figure supplement 3. (E) MBP-ORC1 was incubated with bead-
bound histone peptides with or without the indicated modifications and bound MBP-ORC1 was observed by immunoblotting with anti-MBP antibody
(lower box) or silver staining (upper box). (F–G) Wild-type CCNE1-luciferase reporter assay in U2OS cells. U2OS cells were transiently co-transfected
with 500 ng of 10–4 CCNE1 promoter, 50 ng E2F1, 50 ng DP1 and 20 ng pCMV-LacZ plasmids along with the indicated amounts ORC1 and/or
SUV39H1 plasmids. (F) Increasing amounts of ORC1-Flag or T7-SUV39H1 repress Cyclin E gene promoter. Experiments were carried out in triplicate.
Expression of proteins was confirmed by Immunoblot; a-Tubulin as loading control. Statistical analysis was performed using the Student’s t test.
*p<0.05; **p<0.005; ***p<0.001. (G) ORC1-Flag cooperates with wild type but not mutant SUV39H1 to repress CCNE1 gene expression. The
experiments were carried out in triplicate. Expression of proteins was confirmed by Western blots. a-Tubulin served as a control for equal loading of
each sample. Statistical analysis was performed using the Student’s t test. *p<0.01; **p<0.005; ***p<0.0001. Repression of transcription by ORC1 and
SUV39H1 was also demonstrated using an artificial promoter and tethering the proteins via the GAL4 DNA binding domain in Figure 2—figure
supplement 4. ORC, Origin Recognition Complex; MBP, Maltose binding protein; GST, Glutathione S transferase.
DOI: 10.7554/eLife.12785.006
The following figure supplements are available for figure 2:
Figure supplement 1. ORC1 binds SUV39H1 to control Cyclin E gene transcription.
DOI: 10.7554/eLife.12785.007
Figure supplement 2. ORC1 binds SUV39H1 to control Cyclin E gene transcription.
DOI: 10.7554/eLife.12785.008
Figure supplement 3. ORC1 binds SUV39H1 to control Cyclin E gene transcription.
DOI: 10.7554/eLife.12785.009
Figure supplement 4. ORC1 binds SUV39H1 to control Cyclin E gene transcription.
DOI: 10.7554/eLife.12785.010
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Cell-cycle-dependent association of ORC1, RB, SUV39H1 and CDC6
proteins with the CCNE1 gene promoter
Having established that ORC1 can repress CCNE1 gene transcription in cooperation with the meth-
yltransferase activity of SUV39H1, we investigated the positioning of ORC1, RB and SUV39H1 pro-
teins within the CCNE1 promoter in vivo. A previous publication (Dellino et al., 2013) reported
ORC1 chromatin immuno-precipitation following crosslinking (ChIP) and re-analysis this whole
genome Chip-Seq data revealed a weak ORC1 peak (peak height of 7 reads) within the CCNE1 pro-
moter; however, a duplicate was not reported. Therefore, to test whether ORC1 associated with the
CCNE1 promoter, we modified a chromatin immunoprecipitation (ChIP) method for ORC1 initially
using asynchronously growing MCF7 cells and the immunoprecipitated DNA was analyzed by poly-
merase chain reaction (PCR) using multiple primer pairs across the CCNE1 promoter (Figure 3A).
ORC1 bound to the CCNE1 promoter encompassing the region from -280 to +63 base pairs (probes
E and F), a region that is known to bind the E2F1 transcription factor (see Gene Expression Omnibus
[GEO] transcription factor binding site accession numbers GSM935484 and GSM935477) and con-
tains five E2F1 consensus binding sites (red bars, Figure 3A). Our ChIP analysis also showed that RB
bound to the same regions bound by ORC1, but not to other probes (Figure 3B). When a similar
ChIP analysis was performed using antibodies targeted to SUV39H1, histone H3K9me3 and CDC6,
these proteins bound to the same region (-342 to +63) of the CCNE1 promoter (Figure 3C, also see
Figure 4 below).
We next studied the temporal dynamics of protein binding to the CCNE1 promoter during the
G1 phase of the cell cycle in synchronized U2OS cells. In this analysis, cells were blocked in mitosis
with nocodazole and released into the next G1 phase and ChIP analyses for ORC1, CDC6, RB and
SUV39H1 were performed using primer pairs B and E (Figures 4A and B). ORC1 and RB bound to
the probe E region, but not the probe B region, at 3 hr post mitosis, and then binding was reduced
at 6 hr and eliminated by 9 hr (Figure 4A), even though ORC1 protein remained in the cell
(Figure 4C). SUV39H1 was detected at 3 and 6 hr, but not at 9 hr. Interestingly, CDC6 transiently
bound to the promoter only at 6 hr (Figure 4B), precisely the time when Cyclin E proteins levels dra-
matically increase (Figure 4C). In the following section, we investigated the physiological role of
CDC6 binding to CCNE1 promoter.
CDC6 cooperates with Cyclin E-CDK2 to remove RB from ORC1 and
activate CCNE1 gene transcription
Cyclin E-CDK2 cooperates with CDC6 to stimulate entry from G1 phase into S-phase of the mamma-
lian cell division cycle (Cook et al., 2002; Coverley et al., 2002; Hateboer et al., 1998). Since
CDC6 protein levels increase during late G1 phase (Hateboer et al., 1998; Mendez and Stillman,
2000) and CDC6 binds ORC1 (Figure 2A), we hypothesized that CDC6 may help alleviate ORC1-
mediated repression of the CCNE1 gene. CDC6 and Cyclin E-CDK2 were purified and increasing
amounts were titrated into a mixture containing purified RB and ORC1 (Figure 5—figure supple-
ment 1) and the interaction between RB and ORC1 was monitored. MBP-ORC1 bound to CDC6
(Figure 5A) and increasing amounts of Cyclin E-CDK2 did not interfere with this interaction
(Figure 5B). Moreover, increased binding between CDC6 and ORC1 did not interfere with binding
between ORC1 and RB (Figure 5B). Cyclin E-CDK2 disrupted the interaction between ORC1 and RB
(Figure 5C and Figure 2—figure supplement 2A), but it took relatively high levels of Cyclin
E-CDK2. Importantly, the addition of CDC6 along with CyclinE-CDK2 cooperatively disrupted the
interaction between ORC1 and RB, even at low concentrations of Cyclin E-CDK2 (Figure 5C). As
shown before with Xenopus proteins (Furstenthal et al., 2001), human CDC6 bound to Cyclin
E-CDK2 in a manner dependent on the CDC6 Cyclin ’Cy’ binding motif CDC694RRL96 but not to the
CDC694ARA96’Cy’ mutant (Figure 5D).
Based upon the biochemical data, we hypothesized that CDC6 and Cyclin E-CDK2 cooperated to
relieve ORC1-SUV39H1-RB-mediated repression of CCNE1. If this is the case, then CDC6 overex-
pression should increase CCNE1 expression in vivo. To test this hypothesis, we expressed GFP-
tagged CDC6 wild type or its ’Cy’ mutant in nocodazole arrested U2OS cells and released them
from the nocodazole block to estimate the level of endogenous Cyclin E protein at different times in
G1. Expression of wild type CDC6 but not its ’Cy’ mutant led to an increase in the endogenous level
of Cyclin E protein (Figure 5E). In fact, the Cdc6 ’Cy’ mutant acted as a dominant negative to
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Figure 3. Binding of ORC1, RB, SUV39H1 and CDC6 proteins to the CCNE1 promoter. (A) Schematic of the
CCNE1 promoter and the regions amplified with different primer pairs used for ChIP assay were indicated as
follows: A ( 1462 to  1318); B ( 683 to  575); C ( 456 to  357); D ( 342 to  195); E ( 280 to  143); F ( 159 to
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prevent normal Cyclin E expression. Consistent with these results, overexpression of CDC6 wild type
but not its ’Cy’ mutant further enhanced E2F1-DP1 activated transcription from the CCNE1 pro-
moter (Figure 5F). Based on these data, we suggest that CDC6 co-operates with Cyclin E-CDK2
kinase to abolish the interaction between RB and ORC1, contributing to alleviating the repression
imposed by RB on the CCNE1 gene, leading to CCNE1 gene transcription.
Data presented so far suggests that ORC1-mediated CCNE1 transcriptional repression also
requires SUV39H1. We therefore transfected into RB+ U2OS cells a CCNE1-luciferase reporter plas-
mid with E2F1-DP1 and depleted ORC1, SUV39H1 or CDC6 using siRNA (Figure 6A). Depletion of
Figure 3 continued
analyzed by chromatin immunoprecipitation at the CCNE1 promoter in asynchronous growing MCF7 cells. ORC1
and RB are mouse antibodies, while SUV39H1 and CDC6 are rabbit antibodies. In the marker lanes, the two bands
are 100 and 200 base pairs. The experiments were done in triplicate and two of these experiments are shown.
DOI: 10.7554/eLife.12785.011
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DOI: 10.7554/eLife.12785.012
Hossain and Stillman. eLife 2016;5:e12785. DOI: 10.7554/eLife.12785 9 of 22
Research article Biochemistry Genes and Chromosomes
A 
B 
M
B
P
-G
F
P
-O
R
C
1
 
c
E
/2
 o
r 
G
C
6
 
M
B
P
-R
B
 
0 0 0 0 0 0 5 10 15 20 25 0 
10 20 30 40 50 0 10 20 30 40 50 0 
20 20 20 20 20 20 0 0 0 0 0 0 
20 20 20 20 20 20 20 20 20 20 20 20 
Input 
(2.5%) 
CycE-CDK2 (nM) 
GST-CDC6 (nM) 
MBP-RB (nM) 
MBP-GFP-ORC1 (nM) 
-ORC1 
-GST 
-RB 
-Cyclin E 
(20%) 
-GFP IP 
C 
M
B
P
-G
F
P
-O
R
C
1
 
c
E
/2
 o
r 
G
C
6
 
M
B
P
-R
B
 
0 0 0 0 0 0 10 20 30 40 50 0 
5 10 15 20 25 0 5 10 15 20 25 0 
20 20 20 20 20 20 20 20 20 20 20 20 
20 20 20 20 20 20 20 20 20 20 20 20 
Input 
(2.5%) 
CycE-CDK2 (nM) 
GST-CDC6 (nM) 
MBP-RB (nM) 
MBP-GFP- ORC1 (nM) 
-ORC1 
-GST 
-RB 
-Cyclin E 
(20%) 
-GFP IP 
In
p
u
t 
(5
%
) 
G
S
T
 
G
S
T
 C
D
C
6
 W
T
 
G
S
T
 C
D
C
6
 A
-A
 
-Cyclin E 
+ + Cyclin E-CDK2 + + 
D 
G
F
P
 
G
F
P
-C
D
C
6
 W
T
 
G
F
P
-C
D
C
6
 A
-A
 
G
F
P
 
G
F
P
-C
D
C
6
 W
T
 
G
F
P
-C
D
C
6
 A
-A
 
G
F
P
 
G
F
P
-C
D
C
6
 W
T
 
G
F
P
-C
D
C
6
 A
-A
 
G
F
P
 
G
F
P
-C
D
C
6
 W
T
 
G
F
P
-C
D
C
6
 A
-A
 
0 h 3 h 6 h 9 h 
-GFP 
-Cyclin E 
-Tubulin 
E 
F 
CycE-CDK2 (nM) 
GST-CDC6 (nM) 
MBP-RB (nM) 
MBP or MBP-GFP-ORC1 (nM) 
0 0 0 0 0 0 5 10 15 20 25 0 
10 20 30 40 50 0 10 20 30 40 50 0 
20 20 20 20 20 20 20 20 20 20 20 20 
M
B
P
-G
F
P
-O
R
C
1
 
c
E
/2
 o
r 
G
C
6
 
M
B
P
-R
B
 
Input 
(2.5%) 
MBP MBP-GFP-ORC1 
-ORC1 
-GST 
-RB 
-Cyclin E 
(20%) 
20 20 20 20 20 20 0 0 0 0 0 0 
-GFP IP 
+  + + + + + + 
  0.4 0.3   0.5  
  0.3 0.4 0.5    
E2F1/DP1 
GFP-CDC6 WT (ug) 
GFP-CDC6 A-A (ug) 
-GFP 
-Tubulin 
R
L
U
 
0 
0.25 
0.5 
0.75 
1 
1.25 
1.5 
1.75 
2 
*** 
*** 
*** 
** 
* * * 
Figure 5. CDC6 co-operates with Cyclin E-CDK2 to activate E2F1-dependent CCNE1 gene transcription. (A–C) Equimolar amounts of MBP-GFP-ORC1
and MBP-RB proteins were incubated with increasing amounts of GST-CDC6 and/or Cyclin E-CDK2. MBP-GFP-ORC1 protein was immunoprecipitated
with GFP antibody, then immunoblotted with the indicated antibodies. The purified proteins used in these experiments are shown in Figure 5—figure
supplement 1 (A) MBP-GFP-ORC1 binds GST-CDC6. MBP protein served as control. (B) The binding of MBP-GFP-ORC1 protein to either GST-CCD6 in
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either ORC1 or SUV39H1 with two different siRNAs led to significant increases in CCNE1 promoter
activity above its basal, E2F1/DP1-dependent level. In contrast, depletion of CDC6 protein had no
effect on the basal, E2F1/DP1-dependent promoter activity (Figure 6A). We further investigated the
binding to the CCNE1 promoter of SUV39H1 and the presence of its product, the histone H3K9me3
mark, upon depletion of ORC1 protein in asynchronously growing U2OS cells by ChIP assay. Upon
depletion of ORC1 compared to control siRNA the methyltransferase activity of SUV39H1 was drasti-
cally reduced on the CCNE1 promoter as evident by a dramatic reduction in the histone H3K9m3
mark at the promoter, while the binding of SUV39H1 was only slightly reduced (Figure 6B). The
reduced binding of H3K9me3 was most evident within the region -280 to -143 of the CCNE1 pro-
moter, where ORC1 binding was centered (Figure 6B, Figure 6—figure supplement 1). Depletion
of ORC1 also resulted in reduced levels of the histone H3K9me3 mark as well as a slight reduction in
the level of SUV39H1 protein (Figure 6C). Our results support the hypothesis that ORC1 is involved
in transcription repression by recruiting the SUV39H1 protein, which thereby creates the histone
H3K9me3 transcriptional repressor mark on CCNE1 promoter.
To separate the function of ORC1 as a transcription co-repressor from its well-established role in
DNA replication, we identified C-terminus truncation mutants (1–700 aa and 1–768 aa) of ORC1 (full
length ORC1 is 1–861 aa) that were defective in binding to the other ORC subunits, but still capable
of binding RB and SUV39H1 (Figure 7A–C). These ORC1 mutants were fully active in repressing
CCNE1 transcription (Figure 7D), demonstrating that the effects of ORC1 on CCNE1 gene repres-
sion were not due to an indirect effect of the role of ORC in DNA replication.
Discussion
ORC1 in plants is known to activate transcription in via a plant homeodomain (PHD) that is not found
in animal and fungi ORC1 (Sasaki and Gilbert, 2007; de la Paz Sanchez and Gutierrez, 2009). In
contrast, ORC1 in the budding yeast S. cerevisiae binds to the Sir1 protein and is involved in repres-
sion of transcription of mating type genes (Bell et al., 1993; Triolo and Sternglanz, 1996). In Dro-
sophila and animal cells, ORC, including human ORC1, binds the HP1 proteins that are often
involved in transcriptional repression, but a direct link between this interaction and transcription
repression has not been established (Auth et al., 2006; Badugu et al., 2003; Lidonnici et al., 2004;
Pak et al., 1997; Prasanth et al., 2010; Sasaki and Gilbert, 2007). In this report, we have estab-
lished opposing roles for ORC1 and CDC6 in control of transcription of the Cyclin E gene CCNE1.
ORC1, with RB and SUV39H1, bind to the CCNE1 promoter adjacent to the E2F1 transcription factor
binding sites and repress the E2F1-dependent promoter and this repression is relieved by CDC6
that is bound to Cyclin E-CDK2 kinase. Consistent with this model, CDC6 binds to the CCNE1 pro-
moter transiently, just at the time during G1 phase when Cyclin E levels increase dramatically. We
suggest that low levels of both Cyclin E and CDC6, both E2F1-controlled genes, appear upon activa-
tion of Cyclin D-CDK4 (Narasimha et al., 2014). The expression of CDC6-Cyclin E-CDK2 provides
positive feedback, disrupting the repressive RB-ORC1 interaction. The disruption of RB-ORC1
Figure 5 continued
the presence of Cyclin E-CDK2 (left section) or MBP-RB (right section). (C) The binding of MBP-GFP-ORC1 to MBP-RB in the presence of increasing
molar amounts of Cyclin E-CDK2 (right section) or both GST-CDC6 and Cyclin E-CDK2 (left section). (D) GST-pull down assay using GST-CDC6 wild
type or CDC694ARA96 mutant (CDC6A-A) with purified Cyclin E-CDK2 protein followed by Immunoblotting with Cyclin E antibody. GST protein served
as control. (E) Nocodazole arrested U2OS cells were transfected with 500 ng of GFP, GFP-CDC6 wild type or CDC694ARA96 mutant (CDC6A-A)
plasmids, then released into the next cell cycle. At indicated times, whole cell extracts were immunoblotted with specific antibodies against GFP and
Cyclin E. a-Tubulin served as loading control. (F), CCNE1 promoter-luciferase reporter assay in U2OS cells. Cells transiently co-transfected with 500 ng
of 10–4 CCNE1 promoter, 50 ng E2F1, 50 ng DP1 and 20 ng pCMV-LacZ plasmids together with increasing amounts GFP-CDC6 WT or CDC694ARA96
plasmids for 24 hr. Relative luciferase activity was normalized to co-transfected LacZ control. Experiments in triplicate. Protein expression determined by
immunoblot; a-Tubulin as loading control. Statistical analysis was performed using the Student’s t test. *p<0.05; **p<0.001; ***p<0.0005. GFP, Green
fluorescent protein; MBP, Maltose binding protein; GST, Glutathione S transferase.
DOI: 10.7554/eLife.12785.013
The following figure supplement is available for figure 5:
Figure supplement 1. CDC6 co-operates with Cyclin E-CDK2 to activate E2F1-dependent CCNE1 gene transcription.
DOI: 10.7554/eLife.12785.014
Hossain and Stillman. eLife 2016;5:e12785. DOI: 10.7554/eLife.12785 11 of 22
Research article Biochemistry Genes and Chromosomes
E2F1/DP1 +  + + + + + + 
GFP 
siRNA 
#1 #2 #1 #2 #1 #2 
ORC1 
siRNA 
SUV39H1 
siRNA 
CDC6 
siRNA 
-ORC1 
-SUV39H1 
-CDC6 
-RB 
-Tubulin 
R
L
U
 
0 
0.5 
1 
1.5 
2 
2.5 
3 
*** 
** 
*** 
** 
* * 
* 
E ( 280 to 143) 
D ( 342 to 195) 
F ( 159 to +63) 
B ( 683 to 575) 
G (+350 to +490) 
H (+816 to +944) 
C ( 456 to 357) 
A ( 1462 to 1318) 
Control siRNA ORC1 siRNA 
In
p
u
t 
Ig
G
 
-H
3
K
9
m
e
3
 
-S
U
V
3
9
H
1
 
M
a
rk
e
r 
In
p
u
t 
Ig
G
 
-H
3
K
9
m
e
3
 
-S
U
V
3
9
H
1
 
M
a
rk
e
r 
-ORC1 
C
o
n
tr
o
l 
s
iR
N
A
 
O
R
C
1
 s
iR
N
A
 
-Cyclin E 
-H3K9me3 
-ORC3 
-Tubulin 
-SUV39H1 
-CDC6 
B C 
A 
Figure 6. ORC1 depletion decreases association of SUV39H1 and H3K9me3 with the CCNE1 promoter and increases CCNE1 gene transcription. (A)
CCNE1-luciferase reporter assay in U2OS cells. U2OS cells transiently co-transfected with 500 ng of 10–4 CCNE1 promoter, 50 ng E2F1, 50 ng DP1 and
20 ng pCMV-LacZ. U2OS cells were also transiently transfected for 24 hr with two different siRNAs targeting either ORC1, SUV39H1 or CDC6. GFP
siRNA was used as a control. Relative luciferase activity was normalized to co-transfected LacZ control. Depletion of proteins was confirmed by
Immunoblot; a-Tubulin as loading control. Statistical analysis was performed using the Student’s t test. *p<0.005; **p<0.001; ***p<0.0005. (B) The
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interaction further weakens ORC1 association the with promoter and results in a dramatic reduction
in the repressive histone H3K9me3 mark at the promoter, increasing CCNE1 gene transcription and
amplifying the levels of CDC6 and Cyclin E-CDK2 (Figure 8, bottom panel). The opposing expres-
sion levels of ORC1 and CDC6 during the cell cycle (Figure 8, top panel) are consistent with this
model. The production of higher levels of Cyclin E-CDK2 and CDC6 can then function in pre-RC
assembly, as they are known to do (Cook et al., 2002; Coverley et al., 2002; Hateboer et al.,
1998).
Our work also shows that ORC1 binds to CCNE1 promoter and recruits SUV39H1, forming the
repressive H3K9me3 mark that can then bind the HP1 protein. Interestingly, HP1 is known to bind
both SUV39H1 and ORC1 (Prasanth et al., 2010; Stewart et al., 2005). Thus, ORC1 participates in
multiple protein-protein interactions to ensure stable repression of CCNE1 and perhaps other E2F1-
regulated genes during early G1 phase.
In this way ORC1, which binds mitotic chromosomes and is then inherited into the daughter cells
(Kara et al., 2015; Okuno et al., 2001), creates an opportunity to repress CCNE1 gene transcription
and allow the newborn cells time to integrate information to decide whether to proliferate or exit
the cell division cycle. If proliferation and cell division are destined to occur, Cyclin D-CDK4/6 mono-
phosphorylates RB and primes it for Cyclin E-dependent activation of E2F regulated genes
(Narasimha et al., 2014). We show that low levels of CDC6-Cycin-E-CDK2 can, in a feedback loop,
amplify this commitment by antagonizing ORC1-RB interactions (Figure 8). Consistent with the
model, we demonstrated that over-expression of CDC6, but not a CDC6 that cannot bind Cyclin E,
enhances the levels of endogenous Cyclin E during the very earliest period of G1 phase. Cell-cycle
regulated Cyclin E is essential for maintenance of genome stability since cancer cells that have de-
regulated Cyclin E fail to produce sufficient pre-RCs during G1 phase and as a consequence have
problems in S phase and accumulate DNA damage (Ekholm-Reed et al., 2004; Jones et al., 2013;
Odajima et al., 2010). Of interest is our observation that at the time CDC6 is recruited to the
CCNE1 promoter, ORC1 binding to the promoter declines.
In human cells, ORC1 shows a dynamic, temporally regulated nuclear localization pattern such
that in early G1 phase it is distributed in a punctate pattern throughout the nucleus, but in late G1
phase, ORC1 predominantly binds to regions of the genome that replicate late in the subsequent S
phase (Kara et al., 2015). We suggest that the events that occur at the CCNE1 promoter, ORC1
binding first and recruitment of SUV39H1 and RB, followed by recruitment of Cyclin E-CDK2 and
CDC6, may occur at many ORC1 binding sites in the genome, even those sites that are destined to
assemble the entire ORC protein and promote pre-RC formation. SUV39H1 binding to ORC1 may
influence its temporally dynamic nuclear localization during G1 phase. Such a scenario may also
explain observations that have implicated a role for RB in DNA replication (Bosco et al., 2001;
Kennedy et al., 2000; Sterner et al., 1998). The ORC1-CDC6 switch might temporally influence
pre-RC assembly just like it does for CCNE1 gene regulation, a possibility we are investigating.
Materials and methods
Cell culture and cell synchronization, with siRNA treatment or transient
transfection of expression plasmids
U2OS, HEK293 and MCF7 cells were obtained from the Cold Spring Harbor Laboratory cell culture
collection and cultured in DMEM containing high glucose (Gibco) supplemented with 10%
Figure 6 continued
CCNE1 promoter was analyzed for SUV39H1 binding and the presence of the H3K9me3 mark by ChIP assay in U2OS cells treated with either control
siRNA or ORC1 siRNA for 48 hr. The experiments were done in triplicate and one experiment is shown. (C) Immunoblot of protein levels following
control and ORC1 siRNA treatment at different times post nocodazole release. a-Tubulin was used as loading control.
DOI: 10.7554/eLife.12785.015
The following figure supplement is available for figure 6:
Figure supplement 1. The ChIP qPCR bands were quantified using ImageJ software to analyze the extent of binding of SUV39H1 and histone
H3K9me3 to the CCNE1 promoter region (-280 to -143 bp) in ORC1 siRNA treated U2OS cells compared to control siRNA-treated cells.
DOI: 10.7554/eLife.12785.016
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Figure 7. ORC1 mutants separate its role as a transcription co-repressor from its role in DNA replication. (A) HEK293 cells were transfected with ORC1-
Flag or its truncation mutants and GFP-RB as indicated. Whole cell extracts were immunoprecipitated with anti-Flag antibody and immunoprecipitates
were analyzed by immuoblot with the indicated antibodies. (B and C) In vivo interaction between SUV39H1 and ORC1 or its truncation mutants. GFP-
tagged wild-type ORC1 (1–861) or its truncation mutants (1–700 and 1–768) plasmids were co-transfected into HEK293 cells with Flag-SUV39H1 plasmid
and either GFP-vector or empty vector as a control plasmids. Immunoprecipitation with anti-GFP antibody (B) or anti-Flag antibody (C) from cell lysates
of HEK293 cells expressing the indicated constructs, followed by immunoblotting with the indicated antibodies. (D). U2OS cells transiently transfected
for 24 hr with increasing amounts of wild type ORC1-Flag (1–861) or truncation mutants (1–700 and 1–768). Relative luciferase activity normalized to co-
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inactivated fetal calf serum and Penicillin/Streptomycin. RB defective SaOS-2 cells were obtained
from ATCC (HTB-85) and were cultured in McCoy’s media supplemented with 15% inactivated fetal
calf serum and Penicillin/Streptomycin. All the cell lines were tested negative for the mycoplasma
contamination. To synchronize U2OS cells at G2/M boundary, 100 ng/mL of nocodazole was added
to fresh medium for 16 hr. After 16 hr of block the cells were washed two times with 1x Phosphate
Buffered Saline (PBS) and subsequently, released into the fresh media. For depletion of ORC1 pro-
tein in synchronized U2OS cells, the U2OS cells transiently transfected with 100nM of siRNAs (con-
trol GFP as well as ORC1 siRNA) using Lipofectamine RNAiMax and at the same time were treated
with nocodazole, then the cells were incubated and released as described. Plasmids expressing
exogenous genes were transfected using 2.5 mg of DNA except where indicated using lipofectamine
2000 transfection reagents (ThermoFisher Scientific; Waltham, MA). The sequences of the siRNAs
used are listed in the Supplementary file 1.
Plasmid construction and mutagenesis
Plasmids expressing GFP-RB, 10–4 CCNE1 (Addgene: Cyclin E gene) promoter, E2F1, DP1, HDAC1
and pGL2-GAL4-UAS-Luc were purchased from Addgene. pCMV-LacZ plasmid was purchased from
Clontech. Plasmid Flag-SUV39H1 was a gift from Peter Zhou (Dong et al., 2013). ORC1-Flag or its
Figure 7 continued
transfected lacZ control. Experiments were in triplicate. Expression of proteins determined by Immunoblot; a-Tubulin as loading control. Statistical
analysis was performed using the Student’s t test. *p<0.005; **p<0.001; ***p<0.0005. ORC, Origin Recognition Complex.
DOI: 10.7554/eLife.12785.017
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Figure 8. Model showing contrasting roles of DNA replication proteins ORC1 and CDC6 in the regulation of CCNE1 transcription and commitment to
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complexes at different stages of the cell division cycle. Blue arrow, positive feedback inhibition of ORC1-RB interaction.
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mutant derivatives, ORC3-Flag, ORC4-Flag and T7-SUV39H1 plasmids were generated with a C-ter-
minal Flag tag or N-terminal T7 tag in the pLPC vector (McCurrach et al., 1997) (gift from Scott
Lowe, Memorial Sloan Kettering Cancer Center) for mammalian expression. Human ORC1 or its
mutants, RB or its mutants, CDC6 or its mutants and SUV39H1 or its mutants were also cloned into
pEGFP-C1 (Clontech, Mountain View, CA) for transient overexpression in mammalian cells. GAL4-
DBD, GAL4-ORC1 and GAL-SUV39H1 plasmids were made by replacing the GFP insert in pEGFP-C1
constructs with in frame GAL4 DBD sequences. MBP-GFP-ORC1 plasmid is made by cloning GFP-
ORC1 insert (amplified from GFP-ORC1 plasmid) in pMALc2E vector, while MBP-RB plasmid is made
similar to MBP-ORC1 as described previously (Hossain and Stillman, 2012) for protein expression in
bacterial cells. Human RB or its mutants, CDC6 or its mutant, SUV39H1 or its mutant, HP1a and
HDAC1 were also cloned in pGEX-6P1 vector to produce Glutathione S transferase (GST) fusion pro-
teins in bacterial cells. The mutant plasmids were generated following the site directed mutagenesis
protocol (Quickchange, Stratagene, CA). All the plasmid constructs were verified by sequencing.
The oligonucleotide sequences used to generate the plasmids are listed in the Supplementary file
1.
Recombinant protein expression and purification
Wildtype ORC1, GFP-ORC1 and RB were fused to the maltose binding protein (MBP) in frame by
cloning in the bacterial expression vector pMALc2E (New England Biolab). To generate Glutathione
S transferase (GST) fusion proteins, wild type RB or its mutants (R661W and N757F), HDAC1,
SUV39H1 or its fragments, HP1a or CDC6 were cloned into the bacterial expression vector
pGEX6P1 (GE Healthcare Life Sciences, NJ). The MBP fusion recombinant proteins were expressed
and purified using amylose beads according to the procedure described previously (Hossain and
Stillman, 2012). For GST fusion proteins, transformed E. coli BL21 cells with their respective plas-
mids were induced for 12 hr with 0.3 mM of IPTG at 16˚C. The induced cells were pelleted, washed,
and further lysed with sonication in a lysis buffer A containing 25 mM Tris-HCl at pH 7.5, 150 mM
NaCl, 0.02% NP-40, 5 mM benzamidine-HCl, 1 mM phenylmethylsulfonylfluoride, Protease cocktail
inhibitor tablets [Roche], 10% glycerol) plus 100 mg/ml lysozyme. The lysed bacterial cells were cen-
trifuged and the clarified supernatant is incubated with pre-washed Glutathione sepharose beads for
3 hr at 4˚C. The bead-bound proteins were washed with three column volumes of buffer A plus
0.05% NP-40 + 500 mM NaCl and further with five column volumes of buffer A alone. Fusion protein
was eluted in a stepwise manner with buffer A containing 20 mM reduced glutathione, pH7.5. Frac-
tions containing purified proteins were pooled, concentrated, and dialyzed, and protein concentra-
tion was estimated using a standard Bradford protein assay.
Pull down assays
For MBP-RB or MBP-ORC1 pull down assay, the same protocol as described previously was used
(Hossain and Stillman, 2012), except that here we have used a different binding buffer with follow-
ing composition; 25 mM Tris-Cl at pH 7.5, 100 mM KCl, 0.1% Nonidet P-40, 0.1 mM EDTA, 5 mM
magnesium acetate, 1 mM DTT. For MBP-ORC1 pull down, Cyclin E-CDK2 protein was incubated
with wild type GST-RB or its mutants in the presence or absence of 1 mM ATP. The pull down was
further immunoblotted with anti-GST antibody (27-4577-01; GE Healthcare Life Sciences, NJ).
The histone peptide pull down assay followed the procedure described previously (Hossain and
Stillman, 2012) with the minor modification of binding buffer composition (50 mM Tris-HCl at pH
7.5, 150 mM NaCl, 0.05% NP-40). The pull down was silver stained or immunoblotted with anti-MBP
antibody (E8038S; New England Biolab). The biotin-labeled histone H3 peptides were purchased
from AnaSpec (Fremont, CA) and bound to Streptavidin beads (Sigma-Aldrich, St. Louis, MO) prior
to pull down studies.
For GST pull down assay, bead-bound GST fusion proteins (RB, HDAC1, SUV39H1 or its mutants,
HP1a, and GST-CDC6 or its mutant) were incubated with either MBP-ORC1 or MBP-RB or Cyclin
E-CDK2 protein. The composition of binding buffer used in the assay was; 25 mM Tris-Cl at pH 7.5,
150 mM KCl, 0.15% Nonidet P-40, 0.1 mM EDTA, 5 mM magnesium acetate, 1 mM DTT. The pull
down was further immunoblotted with respective anti-GST (27-4577-01; GE Healthcare Life Sciences,
NJ) or anti-Cyclin E antibodies (sc-247; Santa Cruz Biotechnology, Dallas, TX).
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For titration-based binding experiments, increasing molar amounts of GST-CDC6 and/or Cyclin
E-CDK2 along together with equimolar amounts of MBP-RB (20nM) and MBP-GFP-ORC1 (20nM)
were used in different combinations. The reaction mixture was incubated for 4 hr at 4˚C followed by
1 hr more incubation with bead coupled anti-GFP antibody (ABP-NAB-GFPA025; Allele Biotech, San
Diego, CA) to precipitate MBP-GFP-ORC1. The reaction mixture was incubated and washed with
binding buffer with following composition; 25 mM Tris-Cl at pH 7.5, 150 mM KCl, 0.15% Nonidet
P-40, 0.1 mM EDTA, 5 mM magnesium acetate, 1 mM DTT and 1 mM ATP. The pull down was
immunoblotted with the following antibodies; anti-ORC1 antibody (pKS1-40), anti-RB antibody
(#9309; Cell Signaling, Danvers, MA), anti-GST (27-4577-01; GE Healthcare Life Sciences, NJ) and
anti-Cyclin E antibody (sc-247; Santa Cruz Biotechnology, Dallas, TX).
Immunoprecipitation
For expression of proteins, HEK293 cells were transiently transfected with the indicated plasmids
with lipofectamine 2000 transfection reagents (ThermoFisher Scientific). Immunoprecipitation from
HEK293 cells was performed using the procedure described previously (Hemerly et al., 2009) with
slight modification in the protocol. Following expression of proteins, the cells were harvested and
washed in PBS and lysed in a buffer containing 20 mM Tris-HCl pH7.5, 200 mM NaCl, 0.3% NP-40,
5 mM MgCl2, 0.1 mM EDTA, 10% Glycerol, 1 mM DTT, 1 mM CaCl2, 20 uM MG132 and protease as
well as phosphatase inhibitor tablets (Roche). Benzonase (Sigma-Aldrich, St. Louis, MO) was added
to the buffer and the suspension incubated for 30 min on ice with intermittent mixing. The concen-
tration of NaCl and NP-40 was reduced to 100 mM and 0.15%, respectively with dilution buffer after
30 min incubation on ice. The extract was centrifuged at 14, 000 rpm for 15 min at 4˚C. The proteins
were precipitated with specific antibodies as indicated in figure legends using FLAG, GFP, ORC2 or
ORC3 antibodies. The whole cell extract was first incubated with antibodies for 4 hr and subse-
quently, 2 hr with pre-washed gamma bind G sepharose beads with end-to end shaking at 4˚C. The
beads were washed 3 times with washing buffer containing 20 mM Tris-HCl pH7.5, 100 mM NaCl,
0.1% NP-40, 5 mM MgCl2, 0.1 mM EDTA, 10% Glycerol, 1 mM DTT and protease as well as phos-
phatase inhibitor tablets from Roche. Finally, the washed beads were suspended in Laemmli sample
buffer and 8% SDS-PAGE gels were run and immunoblotted. For immunoprecipitation of endoge-
nous ORC1 and SUV39H1 proteins from U2OS or MCF7 cells and SaOS-2 cells, we have used mono-
clonal ORC1 antibody coupled to magnetic beads as described previously (Kara et al., 2015) as well
as rabbit polyclonal SUV39H1 antibody (A302-128A; Bethyl Laboratories), respectively.
For immunoprecipitations, the following antibodies were used: rabbit polyclonal anti-Flag anti-
body (F7425; Sigma), GFP nAb (ABP-NAB-GFPA025; Allele Biotech, San Diego, CA), polyclonal anti-
SUV39H1 antibody (A302-128A; Bethyl Laboratories), mouse monoclonal ORC1 78-1-172
(Kara et al., 2015), rabbit polyclonal anti-ORC2 antibody (CS205-5) (Prasanth et al., 2004), and rab-
bit polyclonal anti-ORC3 (CS1890) antibody (Siddiqui and Stillman, 2007). For immunoblots, mono-
clonal FLAG antibody (F1804; Sigma), polyclonal GFP antibody (G1544; Sigma), monoclonal mouse
SUV39H1 antibody (05–615; Millipore), monoclonal mouse T7 antibody (Cold Spring Harbor Labora-
tory antibody facility), mouse monoclonal anti-ORC1 antibody (pKS1-40) (Hemerly et al., 2009),
monoclonal mouse ORC2 antibody (920-2-44) (Siddiqui and Stillman, 2007), mouse monoclonal
ORC3 antibody (PKS1-16) (Prasanth et al., 2004), goat polyclonal anti-ORC4 antibody (ab9641;
Abcam, Cambridge, MA), monoclonal mouse E2F-1 antibody (KH95; Santa Cruz Biotechnology, Dal-
las, TX) and rabbit GAL4 antibody (sc-577; Santa Cruz Biotechnology, Dallas, TX) were used.
RNA extraction and qRT-PCR
Nocodazole arrested U2OS cells were transfected with 100 nM siRNA (Dharmacon Inc., Lafayette,
CO), and RNA was prepared at the indicated time points post-drug release using the RNeasy Mini
Kit (Qiagen cat. #74104) including on-column DNase digestion (Qiagen cat. # 79254) and eluted in
the supplied RNase-free water. The cDNA used for Q-PCR was prepared from 1mg each RNA sample
using TaqMan Reverse Transcription Reagents (Applied Biosystems #N808-0234) with random hex-
amer priming in a GeneAmp PCR system 9700 thermocycler. Each Q-PCR reaction was prepared
using 2 mL of 1-to-20 diluted cDNA and 13 mL LightCycler 480 SYBR Green I Master Mix (Roche
#04887352001) and were performed in 384-well plates using the LightCycler 480 (Roche) as per
manufacturer’s instructions.
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For semi-quantitative RT-PCR, equal amounts of RNA (0.2 mg) were used for RT-PCR using the
Qiagen’s One-Step RT PCR kit following manufacturer’s instructions. PCR was performed for 22
cycles and subsequently, run on 1.8% agarose gel. The primer sequences used for RT-PCR analysis
are listed in the Supplementary file 1.
Luciferase reporter assay
For the luciferase reporter assay, 0.3 x 106 U2OS cells were seeded in six-well plates. Cells were
transfected with 0.5 mg CCNE1 promoter luciferase plasmid (p10-4), 50 ng E2F1 plasmid, 50 ng of
DP1 plasmid and 20 ng LacZ plasmid. Together with above plasmids, the cells were also transfected
either with ORC1-Flag or its mutants, ORC3-Flag, ORC4-Flag, T7-SUV39H1, GFP-SUV39H1 or its
mutant, GFP-CDC6 or its mutant for overexpression at the indicated amounts in micrograms. The
cells were transfected using Lipofectamine 2000 (Life Technologies) for 24 hr. For GAL4-based lucif-
erase assay, the U2OS cells were transfected with 0.5 mg of GAL4-UAS-Luciferase promoter plasmid
and 20 ng of LacZ plasmid along with GAL4-DBD fused ORC1 or SUV39H1 at the indicated amounts.
In each of the experiments, the amount of plasmid was kept constant by the addition of empty vec-
tor DNA. For siRNA-mediated depletion of proteins and luciferase measurement, 100 nM of specific
siRNAs targeting ORC1, SUV39H1 or CDC6 were used together with p10-4, E2F1/DP1 and LacZ
plasmids. GFP siRNA is used as negative control. b-Galactosidase activity was measured as
described previously (Smale, 2010), while luciferase activity was measured using luciferase (Prom-
ega) luminescent assay kit according to the manufacturer’s instructions. Luciferase activities were
normalized to b-galactosidase activities and denoted as relative light units (RLU). Expression or
depletion of proteins was confirmed by Western blot. All the experiments were done in triplicates.
Chromatin immunoprecipitation
MCF7 and U2OS cells were used for chromatin immunoprecipitation. The cells were harvested by
trypsinization and washed with cold PBS. The cells (3.0x107) were fixed with 1% formaldehyde for 10
min at room temperature. The cross-linking was stopped by addition 125 mM of glycine for 5 min
on ice. The fixed cells were washed with cold PBS and lysed for 10 min on ice with buffer containing
10 mM Tris pH 8.0, 10 mM NaCl, 2 mM MgCl2, 0.4% NP40, 1 mM DTT, 10% Glycerol, protease and
phosphatase inhibitors. Preliminary experiments demonstrated that ORC1 was most efficiently
extracted from the resulting cells by digestion of the cross-linked chromatin with micrococcal nucle-
ase (MNase; Sigma) and extraction with high salt (300–600 mM NaCl). Thus, the nuclei were treated
with MNase with 1 mM CaCl2 at 37˚C (so that most of the extracted DNA ran on an agarose gel as
~1–4 nucleosome length), the reaction was quenched with 2 mM EGTA and washed with buffer con-
taining 10 mM Tris pH 8.0, 10 mM NaCl, 2 mM MgCl2, 1 mM DTT, 10% Glycerol, protease and
phosphatase inhibitors. The pelleted residual nuclei were further lysed in buffer containing 20 mM
Tris pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 300 mM NaCl, 0.5% TritonX-100, 0.05% Sodium Deoxycho-
late, 0.1% IGE-PAL, 1 mM PMSF and protease/phosphatase inhibitors for 30 min at 4˚C with rota-
tion. The lysate was further diluted to bring the salt concentration to 200 mM and sonicated very
briefly. The lysate was centrifuged (20,800 X g in an Eppendorf centrifuge) at 4˚C to pellet down the
debris and supernatant was used for pre-clearing with protein G Dynabeads (Invitrogen) for 2 hr
4˚C. The antibodies were bound to protein G Dynabeads for 5 hr at 4˚C in PBS containing 0.5%
BSA. The antibodies used for chromatin immunoprecipitation were as follows: mouse monoclonal
ORC1 [78-1-172; (Kara et al., 2015)], mouse RB (#9309, Cell Signaling), rabbit polyclonal SUV39H1
(A302-128A; Bethyl Laboratories), rabbit polyclonal CDC6 (CS1881), rabbit polyclonal histone
H3K9me3 (ab8898, Abcam) as well as control mouse and rabbit IgG (Invitrogen). Pre-cleared nuclear
extracts was incubated with antibody-bound beads overnight with rotation at 4˚C. 0.4 ml of the
nuclear extract was used for each IP and 0.1 ml was kept aside for ’Input’ in Q-PCR analysis. Beads
were then washed with three times with low-salt buffer (20 mM Tris pH8.0, 200 mM NaCl, 0.5% Tri-
tonX-100, 0.05% Sodium Deoxycholate, 0.1% IGE-PAL, 1 mM PMSF), three times high-salt buffer
(20 mM Tris pH8.0, 500 mM NaCl, 0.5% TritonX-100, 0.05% Sodium Deoxycholate, 0.1% IGE-PAL,
1 mM PMSF), three times with lithium chloride buffer (20 mM Tris pH8.0, 200 mM NaCl, 250 mM
LiCl, 0.5% TritonX-100, 0.05% Sodium Deoxycholate, 0.1% IGE-PAL, 1 mM PMSF) and twice with TE
buffer (10 mM Tris pH8.0, 1 mM EDTA). Chromatin was eluted from beads twice with 100 ul elution
buffer (100 mM sodium bicarbonate, 1% SDS) at room temperature. Protein-DNA crosslinks in the IP
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samples as well as in input samples were reversed overnight by addition of 300 mM NaCl and 2 ug
RNase A at 65˚C. The ChIP and input samples were then incubated with 60 ug of proteinase K for
2 hr at 42˚C. The samples were further extracted with phenol:chloroform:isoamyl alchol [IAA] (once
for ChIP and twice for input) and once with chloroform extraction. The ethanol precipitation were
done by adding 10 ug of glycogen, washed with 70% ethanol, air dried and then re-suspended in 50
ul of RNase-DNase free water. The purified DNA was used as template in different PCR amplifica-
tions (Applied Biosystems Thermocycler). The sequences of the various primers is listed in
Supplementary file 1. Due to very high GC content of human CCNE1 promoter, the number of PCR
cycles was extensively and independently optimized with different DNA polymerases
(Supplementary file 2) for each primer set to maintain linear amplification in all experiments. PCR
products were resolved by 2% agarose gel electrophoresis. Images of ethidium bromide-stained
DNAs were acquired using an UV trans-illuminator equipped with a digital camera. Intensities of the
amplified PCR bands were quantitated by ImageJ software.
Data analysis
Data are shown as the average ± the standard deviation (SD) of results of at least three independent
experiments. In the luciferase assay, the statistical differences between cells overexpressing ORC1
and/or SUV39H1 or CDC6 or no E2F1/DP1 were compared to E2F1/DP1 alone without overexpres-
sion, and statistically evaluated by Student’s t test analysis. The lines above the bar graph were used
to indicate the statistical differences between overexpressing samples. In the luciferase assay with
depletion of specific proteins, the statistical differences between siRNAs against the ORC1,
SUV39H1 or CDC6 were compared to control GFP siRNA using the Student’s t test.
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